Page 2 - Marriott Larson News Today

Needham & Company LLC reiterated their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $17.00 price target on the stock. Other equities analysts have also recently issued reports about the company. Morgan Stanley began coverage on Recursion Pharmaceuticals in […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price dropped 8% during mid-day trading on Wednesday . The company traded as low as $12.64 and last traded at $12.70. Approximately 818,678 shares traded hands during trading, a decline of 73% from the average daily volume of 3,030,443 shares. The stock had previously closed at […]

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) fell 8% during trading on Wednesday . The stock traded as low as $12.64 and last traded at $12.70. 818,678 shares were traded during mid-day trading, a decline of 73% from the average session volume of 3,030,443 shares. The stock had previously closed at $13.81. […]

Nikko Asset Management Americas Inc. boosted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 10.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 501,977 shares of the company’s stock after buying an additional 47,455 shares during the […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares gapped down prior to trading on Thursday after an insider sold shares in the company. The stock had previously closed at $15.86, but opened at $15.36. Recursion Pharmaceuticals shares last traded at $15.76, with a volume of 1,927,818 shares changing hands. Specifically, COO Tina Marriott Larson […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $15.86, but opened at $15.36. Recursion Pharmaceuticals shares last traded at $15.76, with a volume of 1,927,818 shares. Specifically, COO Tina Marriott Larson […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) COO Tina Marriott Larson sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 29th. The stock was sold at an average price of $7.49, for a total transaction of $22,470.00. Following the completion of the transaction, the chief operating officer now owns 424,160 […]

Schroder Investment Management Group increased its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) by 47.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 159,964 shares of the company’s stock after acquiring an additional 51,119 shares during the period. Schroder Investment Management Group’s holdings in Recursion Pharmaceuticals were worth $1,233,000 at the […]

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) shares fell 3.9% during trading on Friday after an insider sold shares in the company. The stock traded as low as $8.35 and last traded at $8.43. 724,610 shares were traded during mid-day trading, a decline of 49% from the average session volume of 1,433,050 shares. The stock […]

Jackson Creek Investment Advisors LLC purchased a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) during the 4th quarter, Holdings Channel reports. The firm purchased 77,011 shares of the company’s stock, valued at approximately $594,000. Several other large investors have also modified their holdings of the business. Baillie Gifford & Co. grew its […]